“[N]either young age of onset of cannabis use nor high-frequency use of cannabis or the preferred type of cannabis was associated with cannabis-associated psychotic symptoms.”
Topic: Marijuana Research
Browse these news releases for articles that indicate laws or changes on how marijuana research is conducted. For articles about specific topics of “Research Studies” please choose that topic.
Over 90 percent of consumers said that cannabis was either “very,” “somewhat,” or “slightly” effective at managing their pain, improving their sleep, and reducing anxiety-related symptoms.
The cannabis terpenes β-caryophyllene and α-humulene reduced neuropathic pain and “significantly inhibited” tumor growth.
11-hydroxy-THC is one of two primary metabolites formed following cannabis consumption.
Ninety-seven percent of those surveyed said that their condition “was a little, much, or very much better since starting medical cannabis.”
The law seeks to facilitate and fund medical cannabis research, including “research related to the efficacy and potential health effects of various cannabis delivery methods.”
Cannabis terpenes produced pain-relieving effects that were roughly equal to those of morphine.
Researchers identified no differences among those who consumed cannabis or placebo in 27 of 28 performance tests.